Jan Nilsson performs multidisciplinary study in the fields of Surgery and Internal medicine via his papers. Jan Nilsson performs integrative study on Internal medicine and Surgery in his works. He integrates Confidence interval and Relative risk in his studies. He integrates many fields in his works, including Relative risk and Confidence interval. His study connects Optics and Incidence (geometry). His research brings together the fields of Incidence (geometry) and Optics. Jan Nilsson connects TNF inhibitor with Adalimumab in his research. His multidisciplinary approach integrates Adalimumab and Rheumatoid arthritis in his work. His research on Rheumatoid arthritis often connects related topics like TNF inhibitor.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials
O. Abe;R. Abe;K. Enomoto;K. Kikuchi.
The Lancet (2005)
EuroSCORE II dagger
Samer A. M. Nashef;Francois Roques;Linda D. Sharples;Johan Nilsson.
European Journal of Cardio-Thoracic Surgery (2012)
Real-Time Control Systems with Delays
Johan Nilsson.
PhD Theses; TFRT-1049 (1998) (1998)
Pravastatin Treatment Increases Collagen Content and Decreases Lipid Content, Inflammation, Metalloproteinases, and Cell Death in Human Carotid Plaques Implications for Plaque Stabilization
Milita Crisby;Gunilla Nordin-Fredriksson;Prediman K. Shah;Juliana Yano.
Circulation (2001)
Stochastic analysis and control of real-time systems with random time delays
Johan Nilsson;Bo Bernhardsson;Björb Wittenmark.
Automatica (1998)
Thrombus aspiration during ST-segment elevation myocardial infarction.
Ole Fröbert;Bo Lagerqvist;Göran K. Olivecrona;Elmir Omerovic.
The New England Journal of Medicine (2013)
Stimulation of connective tissue cell growth by substance P and substance K.
Jan Nilsson;Anne M. von Euler;Carl-Johan Dalsgaard.
Nature (1985)
Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man
J. Regnstrom;J. Nilsson;P. Tornvall;A. Hamsten.
The Lancet (1992)
Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients.
C-G Ericsson;U de Faire;L Grip;B Svane.
The Lancet (1996)
Inhibition of tumor necrosis factor-alpha reduces atherosclerosis in apolipoprotein E knockout mice
Lena Brånén;Lars Hovgaard;Mihaela Nitulescu;Eva Bengtsson.
Arteriosclerosis, Thrombosis, and Vascular Biology (2004)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Cedars-Sinai Medical Center
Lund University
Lund University
Lund University
Lund University
Karolinska Institute
Lund University
BeammWave AB
Lund University
Lund University
University of Vienna
Sichuan University
University of Hong Kong
South China University of Technology
Karlsruhe Institute of Technology
Georgia Institute of Technology
University of New South Wales
Lanzhou University
The Institute of Statistical Mathematics
Paul Scherrer Institute
The Ohio State University
National Cheng Kung University
Universitat Politècnica de València
Monash University
Penn State Cancer Institute
Mayo Clinic